{"nctId":"NCT00325468","briefTitle":"An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density","startDateStruct":{"date":"2006-05-01","type":"ACTUAL"},"conditions":["Low Bone Mineral Density"],"count":200,"armGroups":[{"label":"AMG 162","type":"EXPERIMENTAL","interventionNames":["Drug: AMG 162"]}],"interventions":[{"name":"AMG 162","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subject must be ambulatory\n* Subject must have atteneded the 20010223 end-of-study visit and have completed all tests and procedures during the end-of-study visit\n* signed informed consent must be obtained before any study-specific procedures\n\nExclusion Criteria:\n\n* Experienced severe and/or serious adverse event which were thought to be related to denosumab administration during the 20010223 study.\n* Developed grade 3 or 4 laboratory abnormalities based on Common Terminology Criteria for Adverse Events v3.0 during the 20010223 study which did not normalized upon follow up or did not have diagnosis or treatment.\n* Newly diagnosed conditions such as hyper/hypo thyroidism, rheumatoid arthritis, other bone diseases, renal disease.\n* Using therapies while participating in the 20010223 study such as oral bisphosphonates, calcitonin, oral strontium, SERMS, systemic glucocortiocosteriods.","healthyVolunteers":false,"sex":"FEMALE","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Lumbar Spine Bone Mineral Density Percent Change From Parent Study 20010223 Baseline to Year 8","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.4","spread":null},{"groupId":"OG001","value":"11.2","spread":null},{"groupId":"OG002","value":"11.0","spread":null},{"groupId":"OG003","value":"16.5","spread":null},{"groupId":"OG004","value":"12.4","spread":null}]}]}]},{"type":"SECONDARY","title":"Bone-Specific Alkaline Phosphatase Percent Change From Parent Study 20010223 Baseline to Year 8","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-55.8","spread":null},{"groupId":"OG001","value":"-44.7","spread":null},{"groupId":"OG002","value":"-52.5","spread":null},{"groupId":"OG003","value":"-44.4","spread":null},{"groupId":"OG004","value":"-54.2","spread":null}]}]}]},{"type":"PRIMARY","title":"Total Hip Bone Mineral Density Percent Change From Parent Study 20010223 Baseline to Year 8","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":null},{"groupId":"OG001","value":"4.3","spread":null},{"groupId":"OG002","value":"2.3","spread":null},{"groupId":"OG003","value":"6.8","spread":null},{"groupId":"OG004","value":"3.4","spread":null}]}]}]},{"type":"PRIMARY","title":"Distal 1/3 Radius Bone Mineral Density Percent Change From Parent Study 20010223 Baseline to Year 8","description":null,"paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-5.2","spread":null},{"groupId":"OG001","value":"1.4","spread":null},{"groupId":"OG002","value":"0.6","spread":null},{"groupId":"OG003","value":"1.3","spread":null},{"groupId":"OG004","value":"-2.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Serum C-Telopeptide Percent Change From Parent Study 20010223 Baseline to Year 8","description":null,"paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-66.4","spread":null},{"groupId":"OG001","value":"-72.0","spread":null},{"groupId":"OG002","value":"-48.0","spread":null},{"groupId":"OG003","value":"-64.6","spread":null},{"groupId":"OG004","value":"-49.8","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":23},"commonTop":["Upper respiratory tract infection","Arthralgia","Back pain","Hypertension","Sinusitis"]}}}